Limnopharma

Private

GranadaHealthcare & Life Scienceshttps://limnopharma.com/

Last Round

Convertible Debt

Oct 5, 2022

Total Funding Raised

$320,000

Company Overview

Limnopharma is a pharmaceutical company that develops new therapies for retinal diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

retinal disease treatmentsmall-molecule drugRetinitis Pigmentosadry AMDeye drop therapyAge-Related Macular Degenerationneuroprotective therapyanti-inflammatory therapyclinical-stage biotechdrug licensingnatural product derivativesophthalmologyrare disease therapyRP treatmentwet AMDDiabetic Retinopathy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Limnopharma Comps

Public and private peers based on sector, stage, and business model.

Limnopharma comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Limnopharma Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Convertible Debt	Oct 5, 2022
Accelerator	Dec 23, 2021
Grant	Dec 20, 2020
Seed	Mar 1, 2019

View all Funding Rounds

Limnopharma Investors

Notable investors and investment history

Limnopharma investors
Investor	Rounds
GENESIS Ventures	Series A, Seed
Center for Technological Development and Innovation	Grant
AcexHealth	Accelerator
Medex Partners	Series A
La Fondation de l'Avenir	Seed

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 5, 2022
Raised funding from Covirán S.C.A.
Dec 23, 2021
$10K round led by AcexHealth

View all signals

Limnopharma Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Limnopharma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Limnopharma's valuation, stock price, and market status.

Firmographic Details

HeadquartersGranada

Year Founded2019

Last FundingOct 5, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.